Tag:
Aleva Neurotherapeutics
Latest Headlines
Latest Headlines
Aleva scores $4.4M for next-gen DBS therapy
Switzerland's Aleva Neurotherapeutics is looking to make a splash with its own next-generation implants for DBS, and it has just scored 4 million Swiss francs ($4.4 million) in Series B to advance the clinical development of its products.
Aleva raises $13.8M in Series A
Lausanne, Switzerland-based Aleva Neurotherapeutics has announced the closing of Series A financing round totaling €9.5 million ($13.8 million). The round was co-led by BioMedInvest AG and BB
